BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 [PMID: 31235994 DOI: 10.3748/wjg.v25.i22.2706]
URL: https://www.wjgnet.com/1007-9327/full/v25/i22/2706.htm
Number Citing Articles
1
Chunchao Wang, Haoyu Wang, Cheng Huang, Chengjun Wu, Tiemin Sun. Precise Control of the Oxidation Reaction in a High-Purity Dexlansoprazole Synthesis Process Using In Situ InfraredOrganic Process Research & Development 2023; 27(6): 1122 doi: 10.1021/acs.oprd.3c00098
2
Asimina Koulouridi, Ippokratis Messaritakis, Nikolaos Gouvas, John Tsiaoussis, John Souglakos. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation—A Special Reference to Colorectal CancerCancers 2020; 13(1): 43 doi: 10.3390/cancers13010043
3
Susanne Kammerer, Marjolijn Duijvestein, Shintaro Sagami, Agnes Ho. Proton pump inhibitors associated with worse outcomes in CD Medicom Conference Report ECCO 2023 2023;  doi: 10.55788/86ae9b90
4
Courtney H. Coschi, Rosalyn A. Juergens. Overcoming Resistance Mechanisms to Immune Checkpoint Inhibitors: Leveraging the Anti-Tumor Immune ResponseCurrent Oncology 2023; 31(1): 1 doi: 10.3390/curroncol31010001
5
Laura Räisänen, Heli Viljakainen, Kaija-Leena Kolho. Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseasesFrontiers in Pediatrics 2023; 11 doi: 10.3389/fped.2023.1157547
6
Muhammad Miftahussurur, Boby Pratama Putra, Yoshio Yamaoka. The Potential Benefits of Vonoprazan as Helicobacter pylori Infection TherapyPharmaceuticals 2020; 13(10): 276 doi: 10.3390/ph13100276
7
Yoshiharu Okuyama, Teppei Okamoto, Daichi Sasaki, Kai Ozaki, Jung Songee, Shingo Hatakeyama, Tatsuya Mikami, Chikara Ohyama. The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, JapanInternational Urology and Nephrology 2022; 54(1): 9 doi: 10.1007/s11255-021-03044-w
8
Carolla El Chamieh, Islam Amine Larabi, Solène M. Laville, Christian Jacquelinet, Christian Combe, Denis Fouque, Maurice Laville, Luc Frimat, Roberto Pecoits-Filho, Céline Lange, Bénédicte Stengel, Natalia Alencar De Pinho, Jean-Claude Alvarez, Ziad A. Massy, Sophie Liabeuf. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney DiseaseToxins 2023; 15(4): 276 doi: 10.3390/toxins15040276
9
Wu Yinhang, Wu Wei, Zhuang Jing, Zhou Qing, Zhou Yani, Wang Yangyanqiu, Han Shuwen. Biological roles of toll-like receptors and gut microbiota in colorectal cancerFuture Microbiology 2022; 17(13): 1071 doi: 10.2217/fmb-2021-0072
10
Judith Wellens, João Sabino, Séverine Vermeire. PPIs and anti-TNF in patients with IBD: a forbidden combination?Gut 2021; 70(12): 2397.1 doi: 10.1136/gutjnl-2021-324040
11
Paulina J. Haight, Quinn Kistenfeger, Courtney J. Riedinger, Wafa Khadraoui, Floor J. Backes, Kristin L. Bixel, Larry J. Copeland, David E. Cohn, Casey M. Cosgrove, David M. O'Malley, Christa I. Nagel, Daniel J. Spakowicz, Laura M. Chambers. The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerGynecologic Oncology 2023; 178: 14 doi: 10.1016/j.ygyno.2023.09.005
12
Claudio Barbiellini Amidei, Rosanna Comoretto, Loris Zanier, Daniele Donà, Anna Cantarutti, Cristina Canova. Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort studyEuropean Respiratory Journal 2020; 56(5): 2000197 doi: 10.1183/13993003.00197-2020
13
Sho Kitamoto, Nobuhiko Kamada. The oral-gut axis: a missing piece in the IBD puzzleInflammation and Regeneration 2023; 43(1) doi: 10.1186/s41232-023-00304-3
14
Cindy Duysburgh, Lynn Verstrepen, Mattia Van den Broeck, Zefferino Righetto, Marcos Perez. Investigation of Enterogermina’s Protective and Restorative Mechanisms on the Gut Microbiota with PPI, Using SHIME TechnologyNutrients 2023; 15(3): 653 doi: 10.3390/nu15030653
15
Xueyan Jia, Yihuai He, Lin Li, Delin Xu. Pharmacological targeting of gastric mucosal barrier with traditional Chinese medications for repairing gastric mucosal injuryFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1091530
16
Nathan Morris, Meghali Nighot. Understanding the health risks and emerging concerns associated with the use of long-term proton pump inhibitorsBulletin of the National Research Centre 2023; 47(1) doi: 10.1186/s42269-023-01107-9
17
Shu Ping Wong, Yi Xian Er, Sen Mui Tan, Soo Ching Lee, Reena Rajasuriar, Yvonne Ai Lian Lim. Oral and Gut Microbiota Dysbiosis is Associated with Mucositis Severity in Autologous Hematopoietic Stem Cell Transplantation: Evidence from an Asian PopulationTransplantation and Cellular Therapy 2023; 29(10): 633.e1 doi: 10.1016/j.jtct.2023.06.016
18
Nele Brusselaers, Jesper Lagergren, Lars Engstrand. Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancerCancer Epidemiology 2019; 62: 101585 doi: 10.1016/j.canep.2019.101585
19
Shizhen Zhou, Chenxi Li, Lixiang Liu, Qinggang Yuan, Ji Miao, Hao Wang, Chao Ding, Wenxian Guan. Gastric microbiota: an emerging player in gastric cancerFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1130001
20
Volker Schirrmacher. Mitochondria at Work: New Insights into Regulation and Dysregulation of Cellular Energy Supply and MetabolismBiomedicines 2020; 8(11): 526 doi: 10.3390/biomedicines8110526
21
I. A. Krylova, V. I. Kupaev, A. V. Ljamin. Microbiological Characteristics of Intestinal Biocenosis of Ambulator Patients Having Behavioral Risk Factors for Chronic Non-Communicable DiseasesThe Russian Archives of Internal Medicine 2021; 11(3): 217 doi: 10.20514/2226-6704-2021-11-3-217-224
22
Chunlan Wu, Yujun Ke, Luying Wan, Xianhe Xie. Impact of Antacid Exposure on Efficacy of Patients Treated with Immune Checkpoint Inhibitors in: A Study Based on 4,818 IndividualsSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3982290
23
Byung Soo Yoo, Alsiddig Elmahdi, Ana Vilela, Steve M. D’Souza, Kevin V. Houston, David A. Johnson. Esophageal Disease and the Role of the Microbiome2023; : 163 doi: 10.1016/B978-0-323-95070-1.00006-0
24
Thomas H. Tranah, Victoria T. Kronsten, Debbie L. Shawcross. Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver TransplantationLiver Transplantation 2022; 28(4): 700 doi: 10.1002/lt.26353
25
Nadji Hannachi, Laurence Camoin-Jau. Drug Response Diversity: A Hidden Bacterium?Journal of Personalized Medicine 2021; 11(5): 345 doi: 10.3390/jpm11050345
26
Meghali Nighot, Pei-Luan Liao, Nathan Morris, Dennis McCarthy, Viszwapriya Dharmaprakash, Inam Ullah Khan, Shannon Dalessio, Kushal Saha, Ashwinkumar Subramaniam Ganapathy, Alexandra Wang, Wei Ding, Gregory Yochum, Walter Koltun, Prashant Nighot, Thomas Ma. Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental ColitisJournal of Crohn's and Colitis 2023; 17(4): 565 doi: 10.1093/ecco-jcc/jjac168
27
Salvatore E. ARAGONA, Giorgio CIPRANDI. Gastric pyrosis and hyperacidity: an outstanding task in clinical practice. The positioning of a new multicomponent medical device containing sodium alginate, tamarind seed extract, and carbonatesGazzetta Medica Italiana Archivio per le Scienze Mediche 2023; 182(5) doi: 10.23736/S0393-3660.23.05040-4
28
M. Yadav, N.S. Chauhan. Overview of the rules of the microbial engagement in the gut microbiome: a step towards microbiome therapeuticsJournal of Applied Microbiology 2021; 130(5): 1425 doi: 10.1111/jam.14883
29
Chin-Chia Wu, Chuan-Yin Fang, Ben-Hui Yu, Chun-Ming Chang, Ta-Wen Hsu, Chung-Lin Hung, Shih-Kai Hung, Wen-Yen Chiou, Jui-Hsiu Tsai. Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal CancerCancers 2023; 15(21): 5304 doi: 10.3390/cancers15215304
30
Olga D. Ostroumova, Aleksey I. Kochetkov, Svetlana V. Batyukina, Sergey V. Cheremushkin. Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A reviewConsilium Medicum 2023; 25(5): 368 doi: 10.26442/20751753.2023.5.202294
31
Aleksandra Danielak, John L Wallace, Tomasz Brzozowski, Marcin Magierowski. Gaseous Mediators as a Key Molecular Targets for the Development of Gastrointestinal-Safe Anti-Inflammatory PharmacologyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.657457
32
Hüseyin S Bozkurt, Ömer Bilen. Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission ratesEuropean Journal of Inflammation 2021; 19: 205873922110482 doi: 10.1177/20587392211048259
33
Claudio Barbiellini Amidei, Fabiana Zingone, Loris Zanier, Cristina Canova. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort StudyInternational Journal of Environmental Research and Public Health 2020; 17(12): 4255 doi: 10.3390/ijerph17124255
34
Danny Jenkins, Ines Modolell. Proton pump inhibitorsBMJ 2023; : e070752 doi: 10.1136/bmj-2022-070752
35
Xiaowen Jiang, Lei Peng, Li Zhang, Zhexuan Li, Tong Zhou, Jingying Zhang, Wenqing Li, Weicheng You, Yang Zhang, Kaifeng Pan. Gastric microbiota and its role in gastric carcinogenesisMalignancy Spectrum 2023;  doi: 10.1002/msp2.15
36
Wen Hu, Yunhao Luo, Xiujuan Yang. Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart DiseaseInternational Journal of General Medicine 2022; : 8685 doi: 10.2147/IJGM.S392767
37
Jiayi Zhang, Chengcheng Zhang, Qingsong Zhang, Leilei Yu, Wei Chen, Yuzheng Xue, Qixiao Zhai. Meta-analysis of the effects of proton pump inhibitors on the human gut microbiotaBMC Microbiology 2023; 23(1) doi: 10.1186/s12866-023-02895-w
38
Miranda Stiernborg, Stefanie Prast-Nielsen, Philippe A. Melas, Maria Skott, Vincent Millischer, Fredrik Boulund, Yvonne Forsell, Catharina Lavebratt. Differences in the gut microbiome of young adults with schizophrenia spectrum disorder: using machine learning to distinguish cases from controlsBrain, Behavior, and Immunity 2024; 117: 298 doi: 10.1016/j.bbi.2024.01.218
39
Tomoko Mizaki, Hironobu Nobata, Shogo Banno, Makoto Yamaguchi, Hiroshi Kinashi, Shiho Iwagaitsu, Takuji Ishimoto, Yukiko Kuru, Masafumi Ohnishi, Ken-ichi Sako, Yasuhiko Ito. Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritisJournal of Pharmaceutical Health Care and Sciences 2023; 9(1) doi: 10.1186/s40780-022-00271-w
40
Manyu Li, Chaofan Zeng, Jiannan Yao, Yang Ge, Guangyu An. The association between proton pump inhibitors use and clinical outcome of patients receiving immune checkpoint inhibitors therapyInternational Immunopharmacology 2020; 88: 106972 doi: 10.1016/j.intimp.2020.106972
41
Nadiya Hussain, Muntaha Naeem, David J. Pinato. Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?Human Vaccines & Immunotherapeutics 2021; 17(1): 55 doi: 10.1080/21645515.2020.1769398
42
Rodney R. Dietert. Microbiome First Medicine in Health and SafetyBiomedicines 2021; 9(9): 1099 doi: 10.3390/biomedicines9091099
43
Lili Yu, Gang Zhao, Lijuan Wang, Xuan Zhou, Jing Sun, Xinxuan Li, Yingshuang Zhu, Yazhou He, Kleovoulos Kofonikolas, Debby Bogaert, Malcolm Dunlop, Yimin Zhu, Evropi Theodoratou, Xue Li. A systematic review of microbial markers for risk prediction of colorectal neoplasiaBritish Journal of Cancer 2022; 126(9): 1318 doi: 10.1038/s41416-022-01740-7
44
Lisanne M. M. Gommers, Joost G. J. Hoenderop, Jeroen H. F. de Baaij. Mechanisms of proton pump inhibitor‐induced hypomagnesemiaActa Physiologica 2022; 235(4) doi: 10.1111/apha.13846
45
Piera Zaccari, Livia Archibugi, Giulio Belfiori, Enrico Nista, Giuseppe dell'Anna, Stefano Crippa, Tommaso Schepis, Matteo Tacelli, Francesca Aleotti, Maria Chiara Petrone, Alberto Mariani, Guido Costamagna, Antonio Gasbarrini, Alberto Larghi, Massimo Falconi, Paolo Giorgio Arcidiacono, Gabriele Capurso. Risk factors for the occurrence of ampullary tumors: A case‐control studyUnited European Gastroenterology Journal 2022; 10(7): 730 doi: 10.1002/ueg2.12281
46
Jixin Chen, Shuqi Chen, Huiyan Luo, Shunqin Long, Xiaobing Yang, Wenfeng He, Wanyin Wu, Sumei Wang. The negative effect of concomitant medications on immunotherapy in non-small cell lung cancer: An umbrella reviewInternational Immunopharmacology 2023; 124: 110919 doi: 10.1016/j.intimp.2023.110919
47
Kiera Murphy, R. Paul Ross, C. Anthony Ryan, Eugene M. Dempsey, Catherine Stanton. Probiotics, Prebiotics, and Synbiotics for the Prevention of Necrotizing EnterocolitisFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.667188
48
Laura Mihaela Trandafir, Otilia Elena Frăsinariu, Elena Țarcă, Lăcrămioara Ionela Butnariu, Maria Magdalena Leon Constantin, Mihaela Moscalu, Oana Raluca Temneanu, Alina Sinziana Melinte Popescu, Marian George Melinte Popescu, Iuliana Magdalena Stârcea, Elena Cojocaru, Stefana Maria Moisa. Can Bioactive Food Substances Contribute to Cystic Fibrosis-Related Cardiovascular Disease Prevention?Nutrients 2023; 15(2): 314 doi: 10.3390/nu15020314
49
Hao Chen, Masaaki Kondo, Nobuyuki Horita, Kenichi Takahashi, Takeshi Kaneko. The Complex Interaction between Proton Pump Inhibitors and Cancer TreatmentCancers 2023; 15(22): 5346 doi: 10.3390/cancers15225346
50
Sofia D. Forssten, Arthur C. Ouwehand. Comprehensive Gut Microbiota2022; : 69 doi: 10.1016/B978-0-12-819265-8.00059-0
51
Aneta Kiecka, Marian Szczepanik. Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probioticsPharmacological Reports 2023; 75(4): 791 doi: 10.1007/s43440-023-00489-x
52
Yuxuan Chen, Zhaojun Wang, Xinli Chen, Guanqun Chao, Shuo Zhang. The role of gut microbiota and metabolites in regulating the immune response in drug-induced enteritisJournal of Applied Microbiology 2023; 134(3) doi: 10.1093/jambio/lxad032
53
Saurabh Kedia, Vineet Ahuja. Human gut microbiome: A primer for the clinicianJGH Open 2023; 7(5): 337 doi: 10.1002/jgh3.12902
54
Melissa A. Burmeister, Tara E. Smith, Timothy K. Fincher, Abby J. Weldon. Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesityFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1205490
55
Dibya L. Praharaj, Anil C. Anand. Nutrition in Viral HepatitisCurrent Hepatology Reports 2023; 22(1): 9 doi: 10.1007/s11901-023-00596-6
56
Aref Yarahmadi, Hamed Afkhami. The role of microbiomes in gastrointestinal cancers: new insightsFrontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1344328
57
Piotr Dziechciarz, Katarzyna Krenke, Hania Szajewska, Andrea Horvath. Lactobacillus rhamnosus GG Usage in the Prevention of Gastrointestinal and Respiratory Tract Infections in Children with Gastroesophageal Reflux Disease Treated with Proton Pump Inhibitors: A Randomized Double-Blinded Placebo-Controlled TrialPediatric Gastroenterology, Hepatology & Nutrition 2020; 23(3): 251 doi: 10.5223/pghn.2020.23.3.251
58
Marie Perret, Aurélie Bertaut, Julie Niogret, Sophie Marilier, Pierre Jouanny, Patrick Manckoundia, Leïla Bengrine-Lefevre, Valérie Quipourt, Jérémy Barben. Associated Factors to Efficacy and Tolerance of Immunotherapy in Older Patients with Cancer Aged 70 Years and Over: Impact of CoprescriptionsDrugs & Aging 2023; 40(9): 837 doi: 10.1007/s40266-023-01048-y
59
Cristina Durán-Rosas, Bryan Adrián Priego-Parra, Eliana Morel-Cerda, Lydia A. Mercado-Jauregui, Carlos Arturo Aquino-Ruiz, Arturo Triana-Romero, Mercedes Amieva-Balmori, José Antonio Velarde-Ruiz Velasco, José María Remes-Troche. Incidence of Small Intestinal Bacterial Overgrowth and Symptoms After 7 Days of Proton Pump Inhibitor Use: A Study on Healthy VolunteersDigestive Diseases and Sciences 2024; 69(1): 209 doi: 10.1007/s10620-023-08162-2
60
Camille Moaligou, Michel Dion, Murad Ishnaiwer, Éric Dailly, Éric Batard, François Javaudin. Pantoprazole promotes sustained intestinal carriage of multidrug-resistant Escherichia coli in amoxicillin-treated miceJournal of Applied Microbiology 2023; 134(10) doi: 10.1093/jambio/lxad223
61
Kazuki Takada, Sebastiano Buti, Melissa Bersanelli, Mototsugu Shimokawa, Shinkichi Takamori, Taichi Matsubara, Tomoyoshi Takenaka, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo, Yoichi Nakanishi, Isamu Okamoto, David J. Pinato, Alessio Cortellini, Tomoharu Yoshizumi. Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockadeEuropean Journal of Cancer 2022; 172: 199 doi: 10.1016/j.ejca.2022.06.002
62
Bihan Li, Ying Liu, Shilong Sun. Proton pump inhibitors display anti‐tumour potential in gliomaCell Proliferation 2023; 56(7) doi: 10.1111/cpr.13321
63
Fang Lu, Yurong Ma, Hui Huang, Yue Zhang, Hui Kong, Yan Zhao, Huihua Qu, Qingguo Wang, Yang Liu, Zhenhui Kang. Edible and highly biocompatible nanodots from natural plants for the treatment of stress gastric ulcersNanoscale 2021; 13(14): 6809 doi: 10.1039/D1NR01099A
64
Marzena Jabczyk, Justyna Nowak, Bartosz Hudzik, Barbara Zubelewicz-Szkodzińska. Microbiota and Its Impact on the Immune System in COVID-19—A Narrative ReviewJournal of Clinical Medicine 2021; 10(19): 4537 doi: 10.3390/jcm10194537
65
Xiao Wei, Jun Yu, Zhengkun Xu, Chun Wang, Yonggui Wu. Incidence, Pathogenesis, and Management of Proton Pump Inhibitor-Induced NephrotoxicityDrug Safety 2022; 45(7): 703 doi: 10.1007/s40264-022-01181-4
66
Angioletta Lasagna, Federica Mascaro, Simone Figini, Sara Basile, Giulia Gambini, Catherine Klersy, Marco Vincenzo Lenti, Antonio Di Sabatino, Alice Di Benedetto, Monica Calvi, Raffaele Bruno, Paolo Sacchi, Paolo Pedrazzoli. Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapyCancer Medicine 2023; 12(19): 19530 doi: 10.1002/cam4.6565
67
Thiruvinvamalai S. Dharmarajan. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for DeprescribingJournal of the American Medical Directors Association 2021; 22(1): 15 doi: 10.1016/j.jamda.2020.09.046
68
Shingo Takashima, Fumio Tanaka, Yunosuke Kawaguchi, Yuki Usui, Kosuke Fujimoto, Yuji Nadatani, Koji Otani, Shuhei Hosomi, Yasuaki Nagami, Noriko Kamata, Koichi Taira, Tetsuya Tanigawa, Toshio Watanabe, Seiya Imoto, Satoshi Uematsu, Yasuhiro Fujiwara. Proton pump inhibitors enhance intestinal permeability via dysbiosis of gut microbiota under stressed conditions in miceNeurogastroenterology & Motility 2020; 32(7) doi: 10.1111/nmo.13841
69
Li-Qi Mao, Yan-Lin Zhou, Shuang-Shuang Wang, Lin Chen, Yue Hu, Lei-Min Yu, Jing-Ming Xu, Bin Lyu. Impact of Helicobacter pylori eradication on the gastric microbiomeGut Pathogens 2021; 13(1) doi: 10.1186/s13099-021-00460-2
70
Heloisa B. Assalin, Kelly Cristiane Gabriel De Almeida, Dioze Guadagnini, Andrey Santos, Caio J. Teixeira, Silvana Bordin, Guilherme Z. Rocha, Mario J. A. Saad. Proton Pump Inhibitor Pantoprazole Modulates Intestinal Microbiota and Induces TLR4 Signaling and Fibrosis in Mouse LiverInternational Journal of Molecular Sciences 2022; 23(22): 13766 doi: 10.3390/ijms232213766
71
Leon Fisher, Alexander Fisher, Paul N Smith. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)Journal of Clinical Medicine 2020; 9(10): 3253 doi: 10.3390/jcm9103253
72
Valentina Fabiano, Flavia Indrio, Elvira Verduci, Valeria Calcaterra, Tudor Lucian Pop, Alessandra Mari, Gian Vincenzo Zuccotti, Fugen Cullu Cokugras, Massimo Pettoello-Mantovani, Olivier Goulet. Term Infant Formulas Influencing Gut Microbiota: An OverviewNutrients 2021; 13(12): 4200 doi: 10.3390/nu13124200
73
Louis Gaucher, Leslie Adda, Alice Séjourné, Camille Joachim, Chaby Guillaume, Claire Poulet, Sophie Liabeuf, Valérie Gras-Champel, Kamel Masmoudi, Aline Houessinon, Youssef Bennis, Benjamin Batteux. Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitorsTherapeutic Advances in Medical Oncology 2021; 13: 175883592110005 doi: 10.1177/17588359211000591
74
Octavio Gómez-Escudero. Benign Anorectal Disorders - An Update2023;  doi: 10.5772/intechopen.103734
75
Alessandro Rizzo, Matteo Santoni, Veronica Mollica, Angela Dalia Ricci, Concetta Calabrò, Antonio Cusmai, Gennaro Gadaleta-Caldarola, Gennaro Palmiotti, Francesco Massari. The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-AnalysisJournal of Personalized Medicine 2022; 12(5): 842 doi: 10.3390/jpm12050842
76
Wei-Ting Wang, Cheng-Yuan Li, Yun-Ting Chang, Ya-Mei Bai, Shih-Jen Tsai, Tzeng-Ji Chen, Shih-Hwa Chiou, Mu-Hong Chen. Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control studyAllergy and Asthma Proceedings 2023; 44(5): 345 doi: 10.2500/aap.2023.44.230035
77
Nele Brusselaers, Marcela Pereira, Johan Alm, Lars Engstrand, Helene Engstrand Lilja. Effect of proton pump inhibitors in infants with esophageal atresia on the gut microbiome: a pilot cohortGut Pathogens 2022; 14(1) doi: 10.1186/s13099-022-00518-9
78
Honorata Mruk-Mazurkiewicz, Monika Kulaszyńska, Karolina Jakubczyk, Katarzyna Janda-Milczarek, Wiktoria Czarnecka, Ewa Rębacz-Maron, Sławomir Zacha, Jerzy Sieńko, Samir Zeair, Bartosz Dalewski, Wojciech Marlicz, Igor Łoniewski, Karolina Skonieczna-Żydecka. Clinical Relevance of Gut Microbiota Alterations under the Influence of Selected Drugs—Updated ReviewBiomedicines 2023; 11(3): 952 doi: 10.3390/biomedicines11030952
79
Monique R. Bidell, Athena L. V. Hobbs, Thomas P. Lodise. Gut microbiome health and dysbiosis: A clinical primerPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2022; 42(11): 849 doi: 10.1002/phar.2731
80
Siriporn Chamniansawat, Nasisorn Suksridechacin, Narongrit Thongon. Current opinion on the regulation of small intestinal magnesium absorptionWorld Journal of Gastroenterology 2023; 29(2): 332-342 doi: 10.3748/wjg.v29.i2.332
81
Magdalena Dzikowiec, Dorota Pastuszak-Lewandoska. The uninvited guests of our microbiome: Helicobacter pylori and Epstein-Barr virus and their role in gastric cancerogenesisPostępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 611 doi: 10.2478/ahem-2021-0008
82
Irene Gullo, Catarina Costa, Susana L. Silva, Cristina Ferreira, Adriana Motta, Sara P. Silva, Rúben Duarte Ferreira, Pedro Rosmaninho, Emília Faria, José Torres da Costa, Rita Câmara, Gilza Gonçalves, João Santos-Antunes, Carla Oliveira, José C. Machado, Fátima Carneiro, Ana E. Sousa. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric CancerCells 2020; 9(6): 1498 doi: 10.3390/cells9061498
83
Zhi‐Hang Tao, Ji‐Xuan Han, Jing‐Yuan Fang. Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiotaHelicobacter 2020; 25(6) doi: 10.1111/hel.12754
84
Ana Almeida-Santos, Daniela Martins-Mendes, Magdalena Gayà-Vidal, Lucía Pérez-Pardal, Albano Beja-Pereira. Characterization of the Oral Microbiome of Medicated Type-2 Diabetes PatientsFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.610370
85
Jong Min Park, Won Hee Lee, Hochan Seo, Ji Young Oh, Dong Yoon Lee, Seong Jin Kim, Ki Baik Hahm. Microbiota changes with fermented kimchi contributed to either the amelioration or rejuvenation of <i>Helicobacter pylori</i>-associated chronic atrophic gastritisJournal of Clinical Biochemistry and Nutrition 2021; 69(1): 98 doi: 10.3164/jcbn.20-123
86
Jianyi Yin, Roy Elias, Lan Peng, Nicholas Levonyak, Annapoorani Asokan, Alana Christie, Nisa Kubiliun, James Brugarolas, Hans J. Hammers. Chronic Use of Proton Pump Inhibitors Is Associated With an Increased Risk of Immune Checkpoint Inhibitor Colitis in Renal Cell CarcinomaClinical Genitourinary Cancer 2022; 20(3): 260 doi: 10.1016/j.clgc.2022.01.017
87
Sarah Al‐Obaydi, Catherine A. Popadiuk, Taha Al‐Shaikhly. Proton pump inhibitors and the risk of acquiring a penicillin allergy labelInternal Medicine Journal 2023; 53(8): 1481 doi: 10.1111/imj.16197
88
Joshua Bilello, Ikenna Okereke. Impact of Environmental and Pharmacologic Changes on the Upper Gastrointestinal MicrobiomeBiomedicines 2021; 9(6): 617 doi: 10.3390/biomedicines9060617
89
Chia-Jung Kuo, Cheng-Yu Lin, Chun-Wei Chen, Chiu-Yi Hsu, Sen-Yung Hsieh, Cheng-Tang Chiu, Wey-Ran Lin. Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control StudyJournal of Personalized Medicine 2021; 11(11): 1063 doi: 10.3390/jpm11111063
90
Saurabh Talathi, Linda Wilkinson, Katie Meloni, Michelle Shroyer, Li Zhang, Zhenying Ding, Peter Eipers, William Van Der Pol, Colin Martin, Reed Dimmitt, Nengjun Yi, Casey Morrow, David Galloway. Factors Affecting the Gut Microbiome in Pediatric Intestinal FailureJournal of Pediatric Gastroenterology & Nutrition 2023; 77(3): 426 doi: 10.1097/MPG.0000000000003828
91
Thomas X Lu, Matthew Dapas, Erika Lin, Trevor Peters, Atsushi Sakuraba. The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis of randomised controlled studiesGut 2021; 70(11): 2076 doi: 10.1136/gutjnl-2020-321609
92
Enrico Pierluigi Spugnini, Stefano Fais. Drug repurposing for anticancer therapies. A lesson from proton pump inhibitorsExpert Opinion on Therapeutic Patents 2020; 30(1): 15 doi: 10.1080/13543776.2020.1704733
93
Cheng-Yuan Li, Ying-Xiu Dai, Yun-Ting Chang, Ya-Mei Bai, Shih-Jen Tsai, Tzeng-Ji Chen, Mu-Hong Chen. Proton Pump Inhibitors Are Associated with Increased Risk of Psoriasis: A Nationwide Nested Case-Control StudyDermatology 2021; 237(6): 884 doi: 10.1159/000517515
94
Luis A. García Rodríguez, Angel Lanas, Montse Soriano-Gabarró, Pareen Vora, Lucía Cea Soriano. Effect of Proton Pump Inhibitors on Risks of Upper and Lower Gastrointestinal Bleeding among Users of Low-Dose Aspirin: A Population-Based Observational StudyJournal of Clinical Medicine 2020; 9(4): 928 doi: 10.3390/jcm9040928
95
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega. Potential proton pump inhibitor–related adverse effectsAnnals of the New York Academy of Sciences 2020; 1481(1): 43 doi: 10.1111/nyas.14428
96
H. B. Isayev, M. R. Ibrahimov, T. H. Salimov. Dependence of the state of the large intestine parietal microflora on the activity of Helicobacter pylori associated chronic gastritisUral Medical Journal 2021; 20(3): 44 doi: 10.52420/2071-5943-2021-20-3-44-48
97
Anna Cantarutti, Claudio Barbiellini Amidei, Camilla Valsecchi, Antonio Scamarcia, Giovanni Corrao, Dario Gregori, Carlo Giaquinto, Jonas Ludvigsson, Cristina Canova. Association of Treated and Untreated Gastroesophageal Reflux Disease in the First Year of Life with the Subsequent Development of AsthmaInternational Journal of Environmental Research and Public Health 2021; 18(18): 9633 doi: 10.3390/ijerph18189633
98
Brian Bicknell, Ann Liebert, Thomas Borody, Geoffrey Herkes, Craig McLachlan, Hosen Kiat. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the MicrobiomeInternational Journal of Molecular Sciences 2023; 24(11): 9577 doi: 10.3390/ijms24119577
99
Satoshi Furune, Takahiro Suzuki, Takashi Honda, Kenta Yamamoto, Kazuhiro Furukawa, Masanao Nakamura, Masatoshi Ishigami, Fumie Kinoshita, Yoshihiro Kadota, Takumi Tochio, Yoshiharu Shimomura, Yoshiki Hirooka, Mitsuhiro Fujishiro, Hiroki Kawashima. Effects of 1‐kestose on microbiome changes caused by vonoprazan: a randomized, double‐blind, placebo‐controlled pilot studyJournal of Gastroenterology and Hepatology 2023;  doi: 10.1111/jgh.16445
100
Sébastien Lopes, Lucile Pabst, Anne Dory, Marion Klotz, Bénédicte Gourieux, Bruno Michel, Céline Mascaux. Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysisFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1070076
101
Pamela A. McCombe, Fleur C Garton, Matthew Katz, Naomi R Wray, Robert D Henderson. What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?Expert Review of Neurotherapeutics 2020; 20(9): 921 doi: 10.1080/14737175.2020.1785873
102
Youssef Bouferraa, Andrea Chedid, Ghid Amhaz, Ahmed El Lakkiss, Deborah Mukherji, Sally Temraz, Ali Shamseddine. The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and ChallengesInternational Journal of Molecular Sciences 2021; 22(15): 8036 doi: 10.3390/ijms22158036
103
Juan Salazar, Pablo Durán, María P. Díaz, Maricarmen Chacín, Raquel Santeliz, Edgardo Mengual, Emma Gutiérrez, Xavier León, Andrea Díaz, Marycarlota Bernal, Daniel Escalona, Luis Alberto Parra Hernández, Valmore Bermúdez. Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age ModulatorInternational Journal of Environmental Research and Public Health 2023; 20(10): 5845 doi: 10.3390/ijerph20105845
104
Oshin Miranda, Peihao Fan, Xiguang Qi, Haohan Wang, M.Daniel Brannock, Thomas Kosten, Neal David Ryan, Levent Kirisci, LiRong Wang. Prediction of adverse events risk in patients with comorbid post-traumatic stress disorder and alcohol use disorder using electronic medical records by deep learning modelsDrug and Alcohol Dependence 2024; 255: 111066 doi: 10.1016/j.drugalcdep.2023.111066
105
Alisa K. Sivapiromrat, Pichatorn Suppakitjanusant, Yanling Wang, Chengcheng Hu, Jose Binongo, William R. Hunt, Samuel Weinstein, Ishaan Jathal, Jessica A. Alvarez, Benoit Chassaing, Thomas R. Ziegler, Andrew T. Gewirtz, Vin Tangpricha. Vitamin D and prebiotics for intestinal health in cystic fibrosis: Rationale and design for a randomized, placebo-controlled, double-blind, 2 x 2 trial of administration of prebiotics and cholecalciferol (vitamin D3) (Pre-D trial) in adults with cystic fibrosisContemporary Clinical Trials Communications 2024; 38: 101278 doi: 10.1016/j.conctc.2024.101278
106
Jody A. Rusch, Brian T. Layden, Lara R. Dugas. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axisFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1130689
107
Axel Dalhoff. Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?Infection 2021; 49(4): 569 doi: 10.1007/s15010-020-01547-9
108
Sadia Tasnim, Aaron L. Miller, Daniel C. Jupiter, Catherine F. Hamilton, Gabriel L. Reep, Timothy S. Krill, Richard B. Pyles, Ikenna C. Okereke. Effects of proton pump inhibitor use on the esophageal microbial communityBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01460-3
109
Sho Kitamoto, Nobuhiko Kamada. Untangling the oral–gut axis in the pathogenesis of intestinal inflammationInternational Immunology 2022; 34(9): 485 doi: 10.1093/intimm/dxac027
110
Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Luigia Stefania Stucci, Alessandro Russo, Enrica Teresa Tanda, Francesco Spagnolo, Francesca Rastelli, Renato Bisonni, Daniele Santini, Marco Russano, Cecilia Anesi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Mario Alberto Occhipinti, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Claudia Bareggi, Olga Nigro, Alessandro Tuzi, Michele De Tursi, Nicola Petragnani, Laura Pala, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Barbara Di Cocco, Domenico Mallardo, Maria Grazia Vitale, David James Pinato, Giampiero Porzio, Corrado Ficorella, Paolo Antonio Ascierto. Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practiceJournal for ImmunoTherapy of Cancer 2020; 8(2): e001361 doi: 10.1136/jitc-2020-001361
111
Larissa Spósito, Giovanna Capaldi Fortunato, Bruna Almeida Furquim de Camargo, Matheus Aparecido dos Santos Ramos, Maurício Palmeira Chaves de Souza, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Exploiting drug delivery systems for oral route in the peptic ulcer disease treatmentJournal of Drug Targeting 2021; 29(10): 1029 doi: 10.1080/1061186X.2021.1904249
112
Yohannes T Ghebre. Proton Pump Inhibitors and Risk of Infection: Is Suppression of Immune Defence Molecules to Blame?US Respiratory & Pulmonary Diseases 2021; 6(1): 3 doi: 10.17925/USPRD.2021.6.1.3
113
Manon Cairat, Marie Al Rahmoun, Marc J. Gunter, Gianluca Severi, Laure Dossus, Agnès Fournier. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal womenBreast Cancer Research 2020; 22(1) doi: 10.1186/s13058-020-01343-1
114
Moataz E. Mohamed, Abdelrahman Saqr, Christopher Staley, Guillaume Onyeaghala, Levi Teigen, Casey R. Dorr, Rory P. Remmel, Weihua Guan, William S. Oetting, Arthur J. Matas, Ajay K. Israni, Pamala A. Jacobson. Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in TransplantationTransplantation 2024;  doi: 10.1097/TP.0000000000004926
115
Cunye Yan, Yue Chen, Chenyu Sun, Mubashir Ayaz Ahmed, Chandur Bhan, Zhichun Guo, Hongru Yang, Yijing Zuo, Yue Yan, Lei Hu, Yiceng Sun, Yao Li, Qin Zhou. Does Proton Pump Inhibitor Use Lead to a Higher Risk of Coronavirus Disease 2019 Infection and Progression to Severe Disease? a Meta-analysisJapanese Journal of Infectious Diseases 2022; 75(1): 10 doi: 10.7883/yoken.JJID.2021.074
116
Emelie C. Rotbain, Max J. Gordon, Noomi Vainer, Henrik Frederiksen, Henrik Hjalgrim, Alexey V. Danilov, Carsten U. Niemann. The CLL comorbidity index in a population-based cohort: a tool for clinical care and researchBlood Advances 2022; 6(8): 2701 doi: 10.1182/bloodadvances.2021005716
117
Xing Cao, Yafei Wang, Wei Huang, Panyun Li, Chongjie Guo, Yuhui Li. The Impact of Concomitant Proton Pump Inhibitors Therapy on Clinical Outcome of Cancer Patients Treated With Immune Checkpoint InhibitorsAmerican Journal of Clinical Oncology 2023; 46(4): 142 doi: 10.1097/COC.0000000000000991
118
Andreas Thalheimer. Chirurgische Behandlung der RefluxkrankheitIm OP 2021; 11(03): 105 doi: 10.1055/a-1220-4293
119
Bijay Gurung, Maranda Stricklin, Shaohua Wang. Gut Microbiota–Gut Metabolites and Clostridioides difficile Infection: Approaching Sustainable Solutions for TherapyMetabolites 2024; 14(1): 74 doi: 10.3390/metabo14010074
120
Tai‐Yung Yi, Tzu‐Rong Peng, Ta‐Wei Wu, An‐Jan Wu. Association between proton pump inhibitor use and the risk of hepatobiliary cancers: A meta‐analysisAdvances in Digestive Medicine 2024;  doi: 10.1002/aid2.13386
121
Andrea Nuzzo, James R. Brown. The Microbiome Factor in Drug Discovery and DevelopmentChemical Research in Toxicology 2020; 33(1): 119 doi: 10.1021/acs.chemrestox.9b00333
122
Natasha Campbell-McBride, Sarah M. Rice, Tamzyn Murphy. Ketogenic2023; : 383 doi: 10.1016/B978-0-12-821617-0.00001-2
123
Carin A. Northuis, Elizabeth J. Bell, Pamela L. Lutsey, Kristen M. George, Rebecca F. Gottesman, Tom H. Mosley, Eric A. Whitsel, Kamakshi Lakshminarayan. Cumulative Use of Proton Pump Inhibitors and Risk of DementiaNeurology 2023; 101(18) doi: 10.1212/WNL.0000000000207747
124
Yasutoshi Shiratori, Takashi Ikeya, Naoki Ishii, Kazuki Yamamoto, Tetsuro Honda, Kenkei Hasatani, Naohiro Yoshida, Tsutomu Nishida, Tetsuya Sumiyoshi, Shu Kiyotoki, Masahiro Arai, Ryota Niikura. Association between the chronic use of gastric acid suppressants and high‐risk colorectal polypsJGH Open 2021; 5(3): 371 doi: 10.1002/jgh3.12503
125
Elizabeth A. Davidson, Calliope Holingue, Andres Jimenez-Gomez, Julia E. Dallman, Baharak Moshiree. Gastrointestinal Dysfunction in Genetically Defined Neurodevelopmental DisordersSeminars in Neurology 2023; 43(04): 645 doi: 10.1055/s-0043-1771460
126
Bhavneet K. Chawla, Robert E. Cohen, Elizabeth M. Stellrecht, Lisa M. Yerke. The influence of proton pump inhibitors on tissue attachment around teeth and dental implants: A scoping reviewClinical and Experimental Dental Research 2022; 8(5): 1045 doi: 10.1002/cre2.616
127
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literatureAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(5): G889 doi: 10.1152/ajpgi.00161.2019
128
Baohui Hong, Rong Chen, Caiyun Zheng, Maobai Liu, Jing Yang. Development and validation of a nomogram for predicting immune‐related pneumonitis after sintilimab treatmentCancer Medicine 2024;  doi: 10.1002/cam4.6708
129
Amr Mohamed, Sylvia L. Asa, Thomas McCormick, Hilmi Al-Shakhshir, Arvind Dasari, Retuerto Mauricio, Iman Salem, Lee M. Ocuin, David Bajor, Richard T. Lee, J. Eva Selfridge, Arash Kardan, Zhenghong Lee, Norbert Avril, Shelby Kopp, Jordan M. Winter, Jeffrey M. Hardacre, John B. Ammori, Mahmoud A. Ghannoum. The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)Current Issues in Molecular Biology 2022; 44(5): 2015 doi: 10.3390/cimb44050136
130
Mariam Zeriouh, Hans Raskov, Lasse Kvich, Ismail Gögenur, Astrid Louise Bjørn Bennedsen. Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic reviewNeoplasia 2023; 43: 100923 doi: 10.1016/j.neo.2023.100923
131
Nele Brusselaers, Omid Sadr-Azodi, Lars Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in SwedenJournal of Gastroenterology 2020; 55(4): 453 doi: 10.1007/s00535-019-01652-z
132
Arun K. Sharma, Akash Sharma, Samridhi Lal, Ashish Kumar, Nirmala K. Yadav, Fauzia Tabassum, Md. Sayeed Akhtar, Mohammad Tarique Imam, Ziyad Saeed Almalki, Monalisa Mukherjee. Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategiesDrug Discovery Today 2023; 28(5): 103558 doi: 10.1016/j.drudis.2023.103558
133
Nele Moreels, Annelies Boven, Oswaldo Gressani, Fredrik L Andersson, Erika Vlieghe, Steven Callens, Lars Engstrand, Johanna Simin, Nele Brusselaers. The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrenceJournal of Antimicrobial Chemotherapy 2024;  doi: 10.1093/jac/dkae012
134
Alexander J Friedman, Anna J Elseth, Joel R Brockmeyer. Proton Pump Inhibitors, Associated Complications, and Alternative Therapies: A Shifting Risk Benefit RatioThe American Surgeon 2022; 88(1): 20 doi: 10.1177/0003134821991988
135
Camilla Virili, Giovanni Bruno, Maria Giulia Santaguida, Lucilla Gargano, Ilaria Stramazzo, Corrado De Vito, Alessia Cicenia, Giulia Scalese, Barbara Porowska, Carola Severi, Marco Centanni. Levothyroxine treatment and gastric juice pH in humans: the proof of conceptEndocrine 2022; 77(1): 102 doi: 10.1007/s12020-022-03056-1
136
Andrew F. Nyein, Shahla Bari, Stephanie Hogue, Yayi Zhao, Bradley Maller, Sybil Sha, Maria F. Gomez, Dana E. Rollison, Lary A. Robinson. Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancerBMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09210-2
137
Alessandro Rizzo, Antonio Cusmai, Francesco Giovannelli, Silvana Acquafredda, Lucia Rinaldi, Andrea Misino, Elisabetta Sara Montagna, Valentina Ungaro, Mariagrazia Lorusso, Gennaro Palmiotti. Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-AnalysisCancers 2022; 14(6): 1404 doi: 10.3390/cancers14061404
138
Heidi Cecilie Villmones, Adrian Halland, Tore Stenstad, Elling Ulvestad, Harald Weedon-Fekjær, Øyvind Kommedal. The cultivable microbiota of the human distal ileumClinical Microbiology and Infection 2021; 27(6): 912.e7 doi: 10.1016/j.cmi.2020.08.021
139
Soo Hee Jeong, Lara Molloy, Edmond Ang, Nuala Helsby. Re-thinking the possible interaction between proton pump inhibitors and capecitabineCancer Chemotherapy and Pharmacology 2022; 90(5): 381 doi: 10.1007/s00280-022-04473-9
140
Aws Hasan, Laith K. Hasan, Bernd Schnabl, Madeline Greytak, Rena Yadlapati. Microbiome of the Aerodigestive Tract in Health and Esophageal DiseaseDigestive Diseases and Sciences 2021; 66(1): 12 doi: 10.1007/s10620-020-06720-6